guanidinium toxin derivatives (SiteOne Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameguanidinium toxin derivatives (SiteOne Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated sodium channels blockers
TargetsVoltage-gated sodium channels
Therapy Area/IndicationsEye Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiteone Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSiteone Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEye Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A